M.G. PHARMA

Wanze ·KBO/BCE: BE 1002.433.830

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	0.3%	20.4%	better than 28% of 6675 sector peers
Net result	€2k	€4k	better than 43% of 6656 sector peers
Equity	€3k	€16k	better than 32% of 6689 sector peers
Gross operating margin	€114k	€24k	better than 84% of 6635 sector peers
Total assets	€767k	€94k	better than 95% of 6679 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€767k
Fixed assets	21/28	€560k
Intangible fixed assets	21	€253k
Tangible fixed assets	22/27	€307k
Current assets	29/58	€207k
Stocks & contracts in progress	3	€116k
Amounts receivable within one year	40/41	€59k
Cash & bank	54/58	€31k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€767k
Equity	10/15	€3k
Contributions / capital	10/11	€1k
Reserves	13	€2k
Amounts payable	17/49	€765k
Amounts payable after one year	17	€592k
Amounts payable within one year	42/48	€171k
Trade debts payable within one year	44	€53k
Income statement
Gross operating margin	9900	€114k
Operating result	9901	€37k
Financial income	75	€84
Financial charges	65	€35k
Result before taxes	9903	€3k
Income taxes	67/77	€970
Net result for the period	9904	€2k
Result to be appropriated	9905	€2k

Summary